Quick Nav
Pharmacy Times
Health Systems Pharmacy Product News

Nexium IV (esomeprazole sodium)

Published Online: Tuesday, November 1, 2005   [ Request Print ]

AstraZeneca (Wilmington, Del) recently received FDA approval for Nexium IV for injection. The product is indicated for intravenous (IV) infusion or injection for the short-term treatment (up to 10 days) of gastroesophageal reflux disease in patients with a history of erosive esophagitis who are unable to take capsules. The recommended adult dosage regimen for the product is either 20 or 40 mg of Nexium IV given once daily by IV injection (=3 minutes) or IV infusion (10 to 30 minutes). Nexium IV is supplied as a freeze-dried powder containing 20 or 40 mg of esomeprazole per single-use vial. For more information, visit www.nexium-us.com, or call 800-237-8898.

Related Articles
No Result Found

Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-257-0701

Copyright HCPLive 2006-2013
Intellisphere, LLC. All Rights Reserved.

Become a Member
Forgot Password?